Internalization and cytotoxicity of graphene oxide and carboxyl graphene nanoplatelets in the human hepatocellular carcinoma cell line Hep G2

作者: Tobias Lammel , Paul Boisseaux , Maria-Luisa Fernández-Cruz , José M Navas

DOI: 10.1186/1743-8977-10-27

关键词:

摘要: … Two surface-functionalized graphene derivatives, which are used as platform for biomedical applications are graphene oxide (GO) and carboxyl graphene (CXYG) [15]. GO is …

参考文章(75)
Vivian R. Dayeh, Kristin Schirmer, Lucy E.J. Lee, Niels C. Bols, Rainbow Trout Gill Cell Line Microplate Cytotoxicity Test Springer Netherlands. pp. 473- 503 ,(2005) , 10.1007/1-4020-3120-3_16
W Rosenau, D S Friend, E Leopardi, Target cell lysis: ultrastructural and cytoskeletal alterations. Journal of Immunology. ,vol. 133, pp. 3429- 3436 ,(1984)
Margit Pavelka, Roth, J. (Jürgen), Prof. Dr. Dr, Functional Ultrastructure: Atlas of Tissue Biology and Pathology ,(2011)
Paul L. McNeil, Repairing a torn cell surface: make way, lysosomes to the rescue Journal of Cell Science. ,vol. 115, pp. 873- 879 ,(2002) , 10.1242/JCS.115.5.873
Ad M. Knaapen, Paul J.A. Borm, Catrin Albrecht, Roel P.F. Schins, Inhaled particles and lung cancer. Part A: Mechanisms. International Journal of Cancer. ,vol. 109, pp. 799- 809 ,(2004) , 10.1002/IJC.11708
Xinyuan Liu, Robert H. Hurt, Agnes B. Kane, Biodurability of single-walled carbon nanotubes depends on surface functionalization Carbon. ,vol. 48, pp. 1961- 1969 ,(2010) , 10.1016/J.CARBON.2010.02.002
Jim E. Riviere, Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots Wiley Interdisciplinary Reviews-nanomedicine and Nanobiotechnology. ,vol. 1, pp. 26- 34 ,(2009) , 10.1002/WNAN.24
Anton Lerf, Heyong He, Michael Forster, Jacek Klinowski, Structure of Graphite Oxide Revisited Journal of Physical Chemistry B. ,vol. 102, pp. 4477- 4482 ,(1998) , 10.1021/JP9731821
Liming Zhang, Jingguang Xia, Qinghuan Zhao, Liwei Liu, Zhijun Zhang, Functional Graphene Oxide as a Nanocarrier for Controlled Loading and Targeted Delivery of Mixed Anticancer Drugs Small. ,vol. 6, pp. 537- 544 ,(2010) , 10.1002/SMLL.200901680